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Dwarfism may be due to several musculoskeletal and hor-
monal growth disorders. The most common cause is consid-
ered to be achondroplasia, a condition due to a mutation
affecting the fibroblast growth factor receptor (FGFR) gene
3. Achondroplasia occurs with equal frequency in males and
females. It is inherited in an autosomal dominant manner.1
At least 80% of cases result from a random new mutation.
In sporadic cases, a paternal age older than 36 years is
common.2
Despite an estimated prevalence is 1:25,000 in the general
population, 3 there is little literature concerning the diagnostic
and treatment challenges faced by doctors dealing with CAD
in such patients requiring myocardial revascularization.
2. Case report
A 46-year-old Iraqi male with achondroplasia presented with
intermittent rest angina and dyspnoea for last 1–2 months
relieved by sublingual nitrate. His height was 85 cm, his weight
was 70 kg, and he had severely atrophic limbs with kyphosco-
liosis (Fig. 1). He was having hypertension and dyslipidemia as
risk factors. The electrocardiogram showed Q wave in inferior
leads with T wave inversion. Echocardiogram revealed LV
ejection fraction of 45–50% with RWMA in inferior territory.
CAG was planned via radial artery route in view of femoral
artery access issues and to avoid local bleeding complication.Left radial artery access was taken as preferred route in view
of anticipated tortuosity. There was severe radio-brachial tor-
tuosity (Fig. 2) and great difficulty was encountered in tracking
diagnostic catheter. Angiography revealed TVD with critical
disease in LAD, major diagonal, major OM and RCA proxi-
mal, which was 100% occluded (Figs. 4, 7 and 9). Surgical
revascularization was the initial plan. Heart team was
involved. CABG required multiple grafts but in view of severe
musculoskeletal deformity, surgeons were not optimistic of
suitable grafts. So PTCA was planned after taking informed
consent. Patient was preloaded with Ticagrelor 180 mg, aspirin
325 mg and atorvastatin 80 mg. Unfractionated heparin was
used as the anticoagulant. PTCA +S with DES were done
to RCA, LCX-OM2 and proximal to mid LAD, and POBA
to proximal PLB and diagonal arteries.
PTCA was done via right femoral artery access using 7 Fr
femoral sheath .Ultrasound guided femoral artery puncture
was done. The RCA was cannulated with 7 Fr, 3.5 curve
Judkins right guiding catheter with the catheter tracked over
an amplatz super stiff wire because of the severe aortic-iliac
tortuosity (Fig. 3). Lesion was crossed with 0.01400 whisper
guidewire with the support of a 1.25  15 mm balloon. A
3.5  36 mm DES was deployed across the lesion in RCA at
14 atm after pre-dilatation. After dilating proximal 100%
RCA lesion, another critical lesion was evident in proximal
segment of a very large PLB. Prolonged low pressure dilation
to proximal PLB lesion was done with 2.5  10 semi-compliant
balloon at 6 atm. Distal TIMI 3 flow was achieved at the end
of the procedure (Figs. 5 and 6).
Then LCA was cannulated with 7 Fr, 3.5 curve EBU guid-
ing catheter. A 0.01400 whisper guidewire was then used to cross
the major OM lesion. A 2.5  14 mm DES was deployed0.1016/j.
Figure 1 The patient of achondroplasia.
Figure 2 Radio-brachial artery tortuosity.
Figure 3 Common Iliac artery tortuosity.
Figure 4 RCA proximal 100% occlusion.
2 V. Kumar, V. Kumaracross the lesion from LCX-OM at 14 atm after pre-dilatation.
Post-dilatation distal TIMI 3 flow was achieved (Fig. 10).
Then whisper wire was crossed across diagonal lesion and
0.01400 BMW wire was crossed across LAD lesion. Balloon
dilatation was done to proximal diagonal lesion with
2.5  10 semi-compliant balloon at 8 atm. A 2.5  33 mmPlease cite this article in press as: Kumar V, Kumar V A case of multivessel PTCA in
ehj.2016.03.001DES was deployed across the proximal-mid LAD lesion at
14 atm after pre-dilatation across major diagonal. Post dilata-
tion distal a TIMI 3 flow was achieved (Fig. 8). Right femoral
artery puncture was closed with Perclose Proglide (Abbott
Vascular) suture mediated closure device after completion of
the procedure. Later course in the hospital was uneventful
and he was discharged in a stable condition on day 3 of hospi-
talization. After discharge, the patient was placed on aspirin,
ticagrelor, statin, beta-blocker and ACE inhibitor (ramipril).achondroplasia patient, The Egypt Heart J (2016), http://dx.doi.org/10.1016/j.
Figure 8 LAD – Diagonal: Final result.
Figure 5 After Predilatation to RCA.
Figure 6 RCA – final result.
Figure 7 Critical disease in LAD and diagonal.
A case of multivessel PTCA 33. Discussion
Mortality in general in these individuals for all age groups is
2.27 times more than that of the general population, cardiovas-
cular problems being the most frequent causes of death in per-
sons aged 25–54 years3. Apart from the traditional risk factors,
there seems to be other occult genetic or other unknown fac-
tors responsible for this increased risk. No large cohort studies
have been done to delineate these additional factors till date.
There is dearth of literature regarding the technical aspects
of coronary intervention in this group of individuals. TherePlease cite this article in press as: Kumar V, Kumar V A case of multivessel PTCA in
ehj.2016.03.001are a few reports of coronary artery bypass surgery in these
patients,4,5 and a single report on PCI to RCA as rescue PCI
post thrombolysis6. Option of CABG in the setting of multi-
vessel CAD in an achondroplastic patient may be ruled out
because of non-availability of adequate grafts as in our case.
However there is a report of successful CABG after a phlebog-
raphy of the limbs revealed adequate saphenous veins5, but the
patient had a height of 137 cm height, in our case patient’s
height was 85 cm only. So in such short patients with multives-
sel CAD multivessel PTCA may be the only option to achieve
myocardial revascularization. To our knowledge, this is theachondroplasia patient, The Egypt Heart J (2016), http://dx.doi.org/10.1016/j.
Figure 9 Critical lesion in major OM.
Figure 10 LCX-OM: Final result.
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ehj.2016.03.001first case report of mutivessel PTCA in an achondroplastic
patient. Radial intervention may prove to be particularly chal-
lenging in such cases, but with proper hardware and adequate
skills it may still be feasible to do noncomplex PTCA. Local
bleeding complication was minimized by using USG guided
femoral artery puncture and post procedure use of femoral
artery closure device. Our case demonstrates that patients with
achondroplasia can safely undergo multivessel coronary angio-
plasty without additional risk.
4. Conclusion
Achondroplastic patient having multivessel CAD poses a great
challenge for myocardial revascularization. CABG as an
option may be limited by non-availability of normal saphenous
vein grafts in such patients having severely dysmorphic limbs.
Multivessel PTCA can be safely performed in patients with
dwarfism due to achondroplasia with the available technical
knowhow and hardware. Further studies need to be done to
look into the increased risk of CAD in such population.
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